New Jersey A 4216: Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

Status: Introduced in the Assembly, Referred to Assembly Health and Senior Services Committee (as of 2018-06-21)

State: New Jersey · Session: 218 · Bill: A 4216

Subjects: PHARMACEUTIC

Sponsors: Lampitt, Pamela R.

View New Jersey A 4216 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.